Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)
Form 483 issued January 17, 2017 · Ravensburg, Germany
- Observations
- 5
- Pages
- 2
- FEI number
- 3002270322
In short: On January 17, 2017, FDA issued a Form 483 with 5 observations to Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) in Ravensburg, Baden-Wuerttemberg (FEI 3002270322). Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.160 (general requirements).
At a glance
Observations span 4 systems, led by quality system.
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Investigations were incomplete and did not include a review of the firm's retain samples regarding product…
- 02
On January 11, 2017, I observed the sampling of and for total viable counts and endotoxin…
- 03
Your firm does not perform a specific identity test on incoming API's used in the drug…
- 04
Standalone computer software system does not have audit trail capabilities to independently record the operational history…
This inspection in context
Questions about this 483
What did FDA find at Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)?
FDA listed 5 observations on this Form 483, mostly about quality system, laboratory controls and materials. The most-cited regulation is 21 CFR 211.160 (general requirements). The opening words of each observation are shown on this page.
When was Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse) inspected by FDA?
This Form 483 is dated January 17, 2017.
How do I get the full Form 483 for Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Schuetzenstrasse)?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.